NCT07372872 Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes
| NCT ID | NCT07372872 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hong Kong Metropolitan University |
| Condition | Gestational Diabetes Mellitus (GDM) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-05-01 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot study is to test the feasibility and preliminary impact of "MyGlucoCare," a smartphone-based program designed to support women with gestational diabetes (GDM). The main questions it aims to answer are: Is the "MyGlucoCare" program practical and acceptable for participants? Does it show preliminary signs of improving self-management, blood sugar control, and well-being in women with gestational diabetes (GDM)? Researchers will conduct a single-arm study to gather initial data on the program's use and effects, which will be used to plan a larger future clinical trial. Participants will: Use the "MyGlucoCare" app for 8-12 weeks during their pregnancy. Receive personalized education, support from a clinician, and access to a moderated peer group through the app. Complete questionnaires and log health data via the app at the start, near the end of pregnancy, and after giving birth. Some participants will also take part in an interview to share their feedback on the program.
Eligibility Criteria
Inclusion Criteria: * Pregnant women diagnosed with Gestational Diabetes Mellitus (GDM) via a 75g Oral Glucose Tolerance Test (OGTT), conducted between 24 and 28 weeks of gestation (Hong Kong College of Obstetricians and Gynaecologists, 2016). * Aged 18 years or older. * Own a smartphone with reliable internet access. * Able to read and understand Chinese. Exclusion Criteria: * Pre-existing diagnosis of Type 1 or Type 2 diabetes mellitus. * Known major fetal anomaly. * Concurrent enrollment in any other structured GDM self-management intervention. * Severe mental health conditions.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07372872 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gestational Diabetes Mellitus (GDM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07372872 currently recruiting?
Yes, NCT07372872 is actively recruiting participants. Contact the research team at bluk@hkmu.edu.hk for enrollment information.
Where is the NCT07372872 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07372872 clinical trial?
NCT07372872 is sponsored by Hong Kong Metropolitan University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.